| rosiglitazone / Generic mfg. |
NCT00274495: Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver |
|
|
| Terminated | 4 | 30 | US | Rosiglitazone and Pegasys/Ribavirin | Beth Israel Medical Center | Chronic Hepatitis C Infection, Fatty Liver | | 10/07 | | |
NCT00207402: Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin |
|
|
| Completed | 4 | 34 | US | rosiglitazone, Infergen (interferon alfacon-1), Avandia (rosiglitazone), Ribavirin | Brooke Army Medical Center, InterMune | Hepatitis C | 01/10 | 07/10 | | |
NCT01406704: Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH |
|
|
| Terminated | 4 | 26 | RoW | Rosiglitazone, Avandia, alpha-lipoic acid, Thioctic acid, Rosiglitazone/alpha-lipoic acid, Avandia/Thioctic acid | Seoul St. Mary's Hospital, GlaxoSmithKline | NASH (Non-alcoholic Steato-hepatitis) | 12/10 | 12/13 | | |
NCT00742326: Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections |
|
|
| Terminated | 4 | 13 | US | Pioglitazone, Avandia, Placebo | National Institute of Allergy and Infectious Diseases (NIAID) | HIV, Hepatitis C, Liver Disease, Fatty Liver, Steatosis | 01/13 | 01/13 | | |
